Standardizing Immune-Related Adverse Event Protocols in Oncology
As immunotherapy reshapes the oncology landscape, the emergence of complex immune-related adverse events poses a persistent challenge to patient safety and trial continuity. On August 4, 2026, industry experts will convene to address the necessity of standardized grading and cross-functional coordination in managing these unique clinical complications.
The upcoming webinar, hosted by Xtalks, focuses on the critical intersection of patient retention and proactive safety management. Dr. Gwyn Bebb, SVP and Head of Medical Affairs at Premier Research, will join Senior Medical Director Salini Naidu to explore how rigorous site training and standardized guidelines can mitigate risks associated with immune-based therapies.
Effective management of these events requires seamless collaboration between sponsors, medical monitors, and investigative sites. The session aims to provide actionable strategies for improving trial execution, ensuring that promising oncology assets remain viable while maintaining the highest standards of participant care. The live event is scheduled for 11am EDT, offering a platform for professionals to refine their approach to the evolving demands of oncology research.
Comments (0)
No comments yet. Be the first!